22nd Bio€quity Europe conference

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Milan, or attend from home via a digital pass. Plus take advantage of two bonus days of digital 1x1 meetings.

Navigating Through Talent & Capital Headwinds

• Bio€quity Europe revives face-to-face financial networking in 2022 with “Navigating Through Talent & Capital Headwinds.”
• Rich in science and benefitting from the recent global flood of capital, European biotech now faces two headwinds: The Talent Crunch and prospects of a Capital Crunch.
• The Talent Crunch: European biotech faces the hard reality faced everywhere: Talent has become the rate-limiting factor to building a globally competitive innovation ecosystem.
• The Capital Crunch: After the longest bull run in biotech history, concerns are rising - What will it take to keep investors in the sector?
• Once again, Bio€quity Europe challenges its community to identify solutions to industry pain points, and to build a strategy that will sustain Europe’s innovation engine into the future.

Join your colleagues for the 22nd Bio€quity Europe as biopharma leaders debate industry headwinds, and discuss how to gain the upper hand in a global competition for talent and capital.

Why Attend?

• Debate strategies for navigating through talent and capital headwinds over two-plus days of strategic panels and workshops.
• Understand key talent and capital trends via an exclusive report from Insights Partner, McKinsey & Co.
• Hear from 80+ rising biotechs selected by the BioCentury team.
• Meet 1x1 with potential investors and partners using EBD's partneringONE® System – two days in-person (May 17-18), plus two days digital (May 23-24).
• Network with peers from across the innovation ecosystem.
• Use BioCentury’s BCIQ database to research companies and help prepare for 1x1 meetings.
• Watch all session/presentation recordings for 30 days after the event.
• Your choice: Full-Access Pass or Digital Pass?